This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Amniotic fluid embolism

Authoring team

  • this is a very rare complication of pregnancy, occurring at 4.3 per million pregnancies. Ten deaths due to amniotic fluid embolism occurred in the period 1991-3. This represents 7.8% of direct maternal deaths reported during this period. Maternal age over 25 years is an apparent risk factor (1). No association between amniotic fluid embolism and parity has been observed (1)

  • previously induction or augmentation of labour was thought to be a risk factor for the development of amniotic fluid embolism. However in the period 1991-3 only two cases were associated with augmentation of labour and only one case was associated with induction of labour

  • clinical features
    • sudden collapse, rapidly followed by cyanosis and the development of coagulopathy and bleeding

  • this condition is associated with a mortality rate of up to 80%

In the UK from 2005 to 2010 the rate of fatal AFE in the UK was (3):

  • 0.38/100 000 deliveries, 95% CI 0.22 - 0.61; RR 4.93, 95% CI 1.94 - 12.51, P=0.003

Reference:

  • HMSO (1996). Report on Confidential Enquiries into Maternal Deaths in the United Kingdom 1991-93.
  • Conde-Agudelo A, Romero R. Amniotic fluid embolism: an evidencebased review. Am J Obstet Gynecol 2009;201(5):445.e1-13.
  • Kristufkova A, Borovsky M, Korbel M, Knight M.Amniotic fluid embolism - Investigation of fatal cases in Slovakia in the years 2005-2010 compared with fatal cases in the United Kingdom. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2013 Sep 27.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.